Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007605 · ClinicalTrials.gov registry record · Phase 3
Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 706
- Enrollment target
NCT00007605 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 706 participants.
The verdict
NCT00007605, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 706 participants
- Enrollment target
Study Summary
Atrial fibrillation is the most frequently occurring cardiac arrhythmia, with 1.0-1.5 million cases annually. It is a risk factor for congestive heart failure, and stroke, 75,000 cases of the latter occurring annually in patients with atrial fibrillation. The safety of the most widely used antiarrhythmic agent for this group of patients, quinidine, has been called into question. This study seeks to determine whether two other agents, amiodarone and sotalol, are safe and effective treatments for patients with atrial fibrillation.
Interventions
- DRUG Sotalol
- DRUG Amiodarone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 706 participants |
| Start Date | 1998-04 |
| Est. Completion | 2003-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00007605
The ClinicalTrials.gov registry entry for NCT00007605 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 706 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sotalol is the first listed.
NCT00007605 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00007605 about?
NCT00007605 is a clinical study titled "Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus Rhythm". Atrial fibrillation is the most frequently occurring cardiac arrhythmia, with 1.0-1.5 million cases annually. It is a risk factor for congestive heart failure, and stroke, 75,000 cases of the latter occurring annually in patients with atrial fibrillation. The safety of the most widely used antiarrhy...
What is the current status of trial NCT00007605?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 706 participants. The study started on 1998-04. Estimated completion is 2003-12.
What interventions are being tested in trial NCT00007605?
The interventions under investigation include: Sotalol (DRUG), Amiodarone (DRUG).
Who is sponsoring clinical trial NCT00007605?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.